An integrated model of eicosanoid metabolism and signaling based on lipidomics flux analysis

Biophysical Journal

Volumn 96, Issue 11, 2009, Pages 4542-4551

  Gupta, Shakti ^a   Maurya, Mano Ram ^a   Stephens, Daren L ^b   Dennis, Edward A ^b   Subramaniam, Shankar ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; ICOSANOID; LIPID;

ANALYSIS; ANIMAL CELL; ARTICLE; DATA BASE; ENZYME ACTIVITY; EXPERIMENTAL STUDY; GENE; GENETICS; GENOME; ICOSANOID METABOLISM; KINETICS; LIPIDOMICS; LITERATURE; MODEL; MOUSE; NETWORK LEARNING; NONHUMAN; QUANTITATIVE ANALYSIS; SPECIES; ALGORITHM; CHEMICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; NONLINEAR SYSTEM; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

MAMMALIA;

ALGORITHMS; COMPUTER SIMULATION; EICOSANOIDS; KINETICS; MODELS, CHEMICAL; NONLINEAR DYNAMICS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION;

EID: 68949086653     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2009.03.011     Document Type: Article

References (39)

1. Fahy, E., S. Subramaniam, H. A. Brown, C. K. Glass, A. H. Merrill, Jr., et al. 2005. A comprehensive classification system for lipids. J. Lipid Res. 46:839-862.
2. Wymann, M. P., and R. Schneiter. 2008. Lipid signalling in disease. Nat. Rev. Mol. Cell Biol. 9:162-176.
3. Buczynski, M. W., D. S. Dumlao, and E. A. Dennis. 2009. An integrated omics analysis of eicosanoid biology. J. Lipid Res. Epub ahead of print.
4. Funk, C. D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 294:1871-1875.
5. Simmons, D. L., R. M. Botting, and T. Hla. 2004. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 56:387-437.
6. Wang, D., S. C. Miller, and J. Kopecek. 2005. Targeted drug delivery for musculoskeletal diseases. Adv. Drug Deliv. Rev. 57:935-937.
7. Couzin, J. 2004. Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors. Science. 306:384-385.
8. Yang, K., W. Ma, H. Liang, Q. Ouyang, C. Tang, et al. 2007. Dynamic simulations on the arachidonic acid metabolic network. PLOS Comput. Biol. 3:e55.
9. LIPID Metabolites And Pathways Strategy, (LIPID MAPS). http://www.lipidmaps.org. Accessed Mar. 16, 2009.
10. Gijon, M. A., and C. C. Leslie. 1999. Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J. Leukoc. Biol. 65:330-336.
11. Monick, M. M., A. B. Carter, D. M. Flaherty, M. W. Peterson, and G. W. Hunninghake. 2000. Protein kinase C ζ plays a central role in activation of the p42/44 mitogen-activated protein kinase by endotoxin in alveolar macrophages. J. Immunol. 165:4632-4639.
12. Pettus, B. J., K. Kitatani, C. E. Chalfant, T. A. Taha, T. Kawamori, et al. 2005. The coordination of prostaglandin E2 oroduction by sphingosine-1-phosphate and ceramide-1-phosphate. Mol. Pharmacol. 68:330-335.
13. Hwang, D. 2001. Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways. FASEB J. 15:2556-2564.
14. Rao, K. M. K. 2001. MAP kinase activation in macrophages. J. Leukoc. Biol. 69:3-10.
15. Qi, H.-Y., and J. H. Shelhamer. 2005. Toll-like receptor 4 signaling regulates cytosolic phospholipase A2 activation and lipid generation in lipopolysaccharide-stimulated macrophages. J. Biol. Chem. 280:38969-38975.
16. Raetz, C. R. H., T. A. Garrett, C. M. Reynolds, W. A. Shaw, J. D. Moore, et al. 2006. Kdo2-lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4. J. Lipid Res. 47:1097-1111.
17. Eliopoulos, A. G., C. D. Dumitru, C. C. Wang, J. H. Cho, and P. N. Tsichlis. 2002. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J. 21:4831-4840.
18. Kyoto Encyclopedia of Genes and Genomes (KEGG). http://www.genome.ad.jp/ kegg/. [Mar. 16, 2009].
19. Junker, B. H., C. Klukas, and F. Schreiber. 2006. VANTED: A system for advanced data analysis and visualization in the context of biological networks. BMC Bioinformatics. 7:109.
20. Stephanopoulos, G., A. Aristidou, and J. Nielsen. 1998. Metabolic Engineering: Principles and Methodologies. Academic Press, San Diego.
21. Buczynski, M. W., D. L. Stephens, R. C. Bowers-Gentry, A. Grkovich, R. A. Deems, et al. 2007. TLR-4 and sustained calcium agonists synergistically produce eicosanoids independent of protein synthesis in RAW264.7 cells. J. Biol. Chem. 282:22834-22847.
22. Maurya, M. R., and S. Subramaniam. 2007. A kinetic model for calcium dynamics in RAW 264.7 cells: 1. Mechanisms, parameters, and subpopulational variability. Biophys. J. 93:709-728.
23. Famili, I., R. Mahadevan, and B. O. Palsson. 2005. k-Cone analysis: determining all candidate values for kinetic parameters on a network scale. Biophys. J. 88:1616-1625.
24. Hamberg, M., J. Svensson, and B. Samuelsson. 1974. Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins. Proc. Natl. Acad. Sci. USA. 71:3824-3828.
25. Pradervand, S., M. R. Maurya, and S. Subramaniam. 2006. Identification of signaling components required for the prediction of cytokine release in RAW 264.7 macrophages. Genome Biol. 7:R11.
26. Reference deleted in proof.
27. Gupta, S., M. R. Maurya, A. Maer, and S. Subramaniam. 2007. Integrated modeling of lipids metabolism and signaling pathways. AIChE Annu. Mtg., Presentation No. 242g Salt Lake City, UT.
28. Naraba, H., M. Murakami, H. Matsumoto, S. Shimbara, A. Ueno, et al. 1998. Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages. J. Immunol. 160:2974-2982.
29. Glaser, K. B., R. Asmis, and E. A. Dennis. 1990. Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism. Platelet-activating factor receptor activation and regulation of phospholipase A2. J. Biol. Chem. 265:8658-8664.
30. Vunta, H., F. Davis, U. D. Palempalli, D. Bhat, R. J. Arner, et al. 2007. The anti-inflammatory effects of selenium are mediated through 15-deoxy-δ12,14-prostaglandin J2 in macrophages. J. Biol. Chem. 282:17964-17973.
31. Rouzer, C. A., A. T. Jacobs, C. S. Nirodi, P. J. Kingsley, J. D. Morrow, et al. 2005. RAW264.7 cells lack prostaglandin-dependent autoregulation of tumor necrosis factor-a secretion. J. Lipid Res. 46:1027-1037.
32. Lysz, T. W., P. Needleman, and J. A. Ferrendelli. 1983. Measurement of prostaglandin biosynthetic capacity in discrete areas of the rabbit hippocampal formation. J. Neurosci. Res. 10:317-326.
33. Roth, G. J., C. J. Siok, and J. Ozols. 1980. Structural characteristics of prostaglandin synthetase from sheep vesicular gland. J. Biol. Chem. 255:1301-1304.
34. Schomburg, I., A. Chang, C. Ebeling, M. Gremse, C. Heldt, et al. 2004. BRENDA, the enzyme database: updates and major new developments. Nucleic Acids Res. 32:D431-D433.
35. Shimizu, T., S. Yamamoto, and O. Hayaishi. 1979. Purification and properties of prostaglandin D synthetase from rat brain. J. Biol. Chem. 254:5222-5228.
36. Tanioka, T., Y. Nakatani, N. Semmyo, M. Murakami, and I. Kudo. 2000. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J. Biol. Chem. 275:32775-32782.
37. Chan, G., J. O. Boyle, E. K. Yang, F. Zhang, P. G. Sacks, et al. 1999. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res. 59:991-994.
38. Schade, S., Y. Bezugla, A. Kolada, S. Kamionka, R. Scheibe, et al. 2002. Diverse functional coupling of cyclooxygenase 1 and 2 with final prostanoid synthases in liver macrophages. Biochem. Pharmacol. 64:1227-1232.
39. Sun, L. K., P. Wahl, G. Bilic, and R. P. Wuthrich. 2001. CD44-mediated cyclooxygenase-2 expression and thromboxane A2 production in RAW 264.7 macrophages. Inflamm. Res. 50:496-499.